Found: 3152
Select item for more details and to access through your institution.
Clinicopathological Studies on the Impact of Grape Seed Extract and L-Carnitine as Cardioprotective Agents Against Doxorubicin-Induced Toxicity in Rats.
- Published in:
- Life (2075-1729), 2024, v. 14, n. 12, p. 1656, doi. 10.3390/life14121656
- By:
- Publication type:
- Article
Mitophagy in Doxorubicin-Induced Cardiotoxicity: Insights into Molecular Biology and Novel Therapeutic Strategies.
- Published in:
- Biomolecules (2218-273X), 2024, v. 14, n. 12, p. 1614, doi. 10.3390/biom14121614
- By:
- Publication type:
- Article
Bacterial pathogenesis: A pneumococcal heart-breaker.
- Published in:
- Nature Reviews Microbiology, 2014, v. 12, n. 11, p. 724, doi. 10.1038/nrmicro3374
- By:
- Publication type:
- Article
Association of body mass index and cardiotoxicity related to anthracyclines and trastuzumab in early breast cancer: French CANTO cohort study.
- Published in:
- 2019
- By:
- Publication type:
- journal article
In this issue July 2024.
- Published in:
- Pediatric Anesthesia, 2024, v. 34, n. 7, p. 587, doi. 10.1111/pan.14939
- Publication type:
- Article
Acute Myocardial Infarction Induced by Ephedrine Alkaloids.
- Published in:
- Pharmacotherapy, 2003, v. 23, n. 12, p. 1645, doi. 10.1592/phco.23.15.1645.31959
- By:
- Publication type:
- Article
Multi-component identification and target cell-based screening of potential bioactive compounds in toad venom by UPLC coupled with high-resolution LTQ-Orbitrap MS and high-sensitivity Qtrap MS.
- Published in:
- Analytical & Bioanalytical Chemistry, 2018, v. 410, n. 18, p. 4419, doi. 10.1007/s00216-018-1097-4
- By:
- Publication type:
- Article
Development of energetic pharmacophore for the designing of 1,2,3,4-tetrahydropyrimidine derivatives as selective cyclooxygenase-2 inhibitors.
- Published in:
- Journal of Computer-Aided Molecular Design, 2012, v. 26, n. 3, p. 267, doi. 10.1007/s10822-011-9540-z
- By:
- Publication type:
- Article
Moderated Poster Session 2 - Comorbidities in heart failure.
- Published in:
- 2015
- Publication type:
- Abstract
Pixantrone containing R‐CPOP as firstline treatment in elderly DLBCL patients with congestive heart failure or high risk of anthracycline induced cardiotoxicity.
- Published in:
- Hematological Oncology, 2023, v. 41, p. 425, doi. 10.1002/hon.3164_312
- By:
- Publication type:
- Article
Cardiotoxicity as an adverse effect of immunomodulatory drugs and proteasome inhibitors in multiple myeloma: A network meta‐analysis of randomized clinical trials.
- Published in:
- Hematological Oncology, 2022, v. 40, n. 2, p. 233, doi. 10.1002/hon.2959
- By:
- Publication type:
- Article
Neurotoxicity‐associated sinus bradycardia after chimeric antigen receptor T‐cell therapy.
- Published in:
- Hematological Oncology, 2022, v. 40, n. 3, p. 482, doi. 10.1002/hon.2976
- By:
- Publication type:
- Article
An integrated view of cisplatin-induced nephrotoxicity, hepatotoxicity, and cardiotoxicity: characteristics, common molecular mechanisms, and current clinical management.
- Published in:
- Clinical & Experimental Nephrology, 2024, v. 28, n. 8, p. 711, doi. 10.1007/s10157-024-02490-x
- By:
- Publication type:
- Article
The role of lipids and uremic toxins in cardiovascular disease in CKD.
- Published in:
- Clinical & Experimental Nephrology, 2014, v. 18, n. 2, p. 255, doi. 10.1007/s10157-013-0864-y
- By:
- Publication type:
- Article
Cardioprotective potential of mitochondria-targeted antioxidant, mito-TEMPO, in 5-fluorouracil-induced cardiotoxicity.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2023, v. 91, n. 5, p. 389, doi. 10.1007/s00280-023-04529-4
- By:
- Publication type:
- Article
Phase I study of pegylated liposomal doxorubicin and cisplatin in patients with advanced osteosarcoma.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2022, v. 89, n. 2, p. 209, doi. 10.1007/s00280-021-04371-6
- By:
- Publication type:
- Article
Cardiovascular toxicity of breast cancer treatment: an update.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Aloin alleviates doxorubicin-induced cardiotoxicity in rats by abrogating oxidative stress and pro-inflammatory cytokines.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2020, v. 86, n. 3, p. 419, doi. 10.1007/s00280-020-04125-w
- By:
- Publication type:
- Article
Cardioprotective effects of dapsone against doxorubicin-induced cardiotoxicity in rats.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Incidence of and risk factors for cardiotoxicity after fluorouracil-based chemotherapy in locally advanced or metastatic gastric cancer patients.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Lactobacillus supplementation prevents cisplatin-induced cardiotoxicity possibly by inflammation inhibition.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2018, v. 82, n. 6, p. 999, doi. 10.1007/s00280-018-3691-8
- By:
- Publication type:
- Article
Absence of cardiotoxicity with prolonged treatment and large accumulating doses of pegylated liposomal doxorubicin.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Allicin ameliorates doxorubicin-induced cardiotoxicity in rats via suppression of oxidative stress, inflammation and apoptosis.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Cardiac safety profile of patients receiving high cumulative doses of pegylated-liposomal doxorubicin: use of left ventricular ejection fraction is of unproven value.
- Published in:
- 2017
- By:
- Publication type:
- journal article
JS-K, a GST-activated nitric oxide donor prodrug, enhances chemo-sensitivity in renal carcinoma cells and prevents cardiac myocytes toxicity induced by Doxorubicin.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Population pharmacokinetic modelling of doxorubicin and doxorubicinol in children with cancer: is there a relationship with cardiac troponin profiles?
- Published in:
- 2017
- By:
- Publication type:
- journal article
Phase Ib dose-finding trial of lapatinib plus pegylated liposomal doxorubicin in advanced HER2-positive breast cancer.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Modulation of cyclophosphamide-induced cardiotoxicity by methyl palmitate.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Phase 1 study to evaluate the effect of the MEK inhibitor trametinib on cardiac repolarization in patients with solid tumours.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Phase 1 study of cardiac safety of TAS-102 in patients with advanced solid tumors.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Overweight in mice, induced by perinatal programming, exacerbates doxorubicin and trastuzumab cardiotoxicity.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Protective effects of mito-TEMPO against doxorubicin cardiotoxicity in mice.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Selective A3 adenosine receptor agonist protects against doxorubicin-induced cardiotoxicity.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Impact of dexrazoxane on doxorubicin-induced aneuploidy in somatic and germinal cells of male mice.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Reproductive hormone levels and differential mitochondria-related oxidative gene expression as potential mechanisms for gender differences in cardiosensitivity to Doxorubicin in tumor-bearing spontaneously hypertensive rats.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2015, v. 76, n. 3, p. 447, doi. 10.1007/s00280-015-2786-8
- By:
- Publication type:
- Article
Prevalence and clinical significance of potential drug-drug interaction in hematopoietic stem cell transplantation.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2015, v. 75, n. 2, p. 393, doi. 10.1007/s00280-014-2657-8
- By:
- Publication type:
- Article
Chemotherapy-Induced Changes in Cardiac Capillary Permeability Measured by Fluorescent Multiple Indicator Dilution.
- Published in:
- Annals of Biomedical Engineering, 2014, v. 42, n. 12, p. 2405, doi. 10.1007/s10439-014-1110-9
- By:
- Publication type:
- Article
Correction to: Investigation of polysaccharide from Radix Aconiti Lateralis Preparata (Fuzi) cardio protective effect on doxorubicin-induced chronic cardiotoxicity.
- Published in:
- 2024
- Publication type:
- Correction Notice
Investigation of polysaccharide from Radix Aconiti Lateralis Preparata (Fuzi) cardio protective effect on doxorubicin-induced chronic cardiotoxicity.
- Published in:
- Journal of Pharmacy & Pharmacology, 2024, v. 76, n. 4, p. 391, doi. 10.1093/jpp/rgae001
- By:
- Publication type:
- Article
Astaxanthin protects against pirarubicin-induced H9c2 cardiomyocytes by adjusting microRNA-494-3p-mediated MDM4/p53 signalling pathway.
- Published in:
- Journal of Pharmacy & Pharmacology, 2023, v. 75, n. 12, p. 1521, doi. 10.1093/jpp/rgad084
- By:
- Publication type:
- Article
Sacubitril/valsartan cardioprotective effect against cisplatin-induced cardiotoxicity via modulation of VEGF/eNOS and TLR4/TNFα/IL6 signalling pathways.
- Published in:
- Journal of Pharmacy & Pharmacology, 2023, v. 75, n. 9, p. 1237, doi. 10.1093/jpp/rgad049
- By:
- Publication type:
- Article
Doxorubicin-induced cardiotoxicity: causative factors and possible interventions.
- Published in:
- Journal of Pharmacy & Pharmacology, 2022, v. 74, n. 12, p. 1677, doi. 10.1093/jpp/rgac063
- By:
- Publication type:
- Article
The Protective Effect of Natural Compounds on Doxorubicin-Induced Cardiotoxicity via Nicotinamide Adenine Dinucleotide Phosphate Oxidase Inhibition.
- Published in:
- Journal of Pharmacy & Pharmacology, 2022, v. 74, n. 3, p. 351, doi. 10.1093/jpp/rgab109
- By:
- Publication type:
- Article
An application of p-sulfonatocalix[6]arenes to attenuate cardiotoxicity of mitoxantrone in vitro: preparation, characterization and evaluation.
- Published in:
- Journal of Pharmacy & Pharmacology, 2022, v. 74, n. 1, p. 41, doi. 10.1093/jpp/rgab154
- By:
- Publication type:
- Article
A review of the protective role of melatonin during phosphine-induced cardiotoxicity: focus on mitochondrial dysfunction, oxidative stress and apoptosis.
- Published in:
- Journal of Pharmacy & Pharmacology, 2017, v. 69, n. 3, p. 236, doi. 10.1111/jphp.12682
- By:
- Publication type:
- Article
Thymol accelerates the recovery of the skeletal muscle of mice injured with cardiotoxin.
- Published in:
- Journal of Pharmacy & Pharmacology, 2016, v. 68, n. 3, p. 352, doi. 10.1111/jphp.12520
- By:
- Publication type:
- Article
Cardioprotective Diet to Prevent Anthracycline-Induced Cardiotoxicity in Patients with Breast Cancer: A Randomized Open-Label Controlled Trial.
- Published in:
- Journal of Integrative & Complementary Medicine, 2024, v. 30, n. 10, p. 995, doi. 10.1089/jicm.2023.0777
- By:
- Publication type:
- Article
Home-Based Buddhist Walking Meditation Mitigates Cardiotoxicity of Anthracycline Chemotherapy in Breast Cancer Patients: A Randomized Controlled Trial.
- Published in:
- Journal of Integrative & Complementary Medicine, 2023, v. 29, n. 9, p. 562, doi. 10.1089/jicm.2022.0778
- By:
- Publication type:
- Article
The protective effects of glycyrrhizin on doxorubicin-induced cardiotoxicity in rats.
- Published in:
- Annals of Medical of Research, 2023, v. 30, n. 10, p. 1276, doi. 10.5455/annalsmedres.2023.08.219
- By:
- Publication type:
- Article
Cardiovascular Adverse Effects of Chemotherapy: Evidence-based Prevention and Treatment Strategies.
- Published in:
- 2023
- By:
- Publication type:
- Letter